Advance ZincTek (ASX:ANO) confirmed that pharmaceuticals, including zinc oxide, are exempt from the 10% US tariff under the Trump administration's executive orders, according to a Monday filing with the Australian bourse.
Accordingly, the company said that it does not expect any negative impact on its US operations related to the tariffs, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.